RxDoctor Payments Data

William Woods, MD

Family Medicine · Bartlesville, OKNPI 1831296219

Payments from drug & device makers

$227in general payments, 2019–2025

Across 14 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$112
  • Pfizer$29
  • AstraZeneca$25
  • Exact Sciences$21
  • Amgen$16
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$13
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$227100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$227 in reported general payments places this provider in the 40th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$63,959
Medicare patients
232
Services billed
906

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide113$109,642
EliquisApixaban49$50,969
JanuviaSitagliptin Phosphate26$31,558
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog29$26,919
FarxigaDapagliflozin Propanediol17$19,507
MounjaroTirzepatide17$17,329
XareltoRivaroxaban18$16,102
VraylarCariprazine Hcl11$14,961
TrintellixVortioxetine Hydrobromide14$9,172
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$6,828
Humalog Kwikpen U-100Insulin Lispro19$5,593
Lantus SolostarInsulin Glargine,hum.Rec.Anlog51$5,584
Atorvastatin Calcium288$5,092
Novolog FlexpenInsulin Aspart17$4,954
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen238$4,371

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$112$109,642113 claims
PfizerEliquis$29$50,96949 claims
AstraZenecaFarxiga$25$19,50717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Bartlesville

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →